• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.中国上海美沙酮维持治疗(MMT)诊所中丙型肝炎病毒感染者、相关服务及丙型肝炎病毒治疗障碍因素。
Harm Reduct J. 2017 Nov 2;14(1):71. doi: 10.1186/s12954-017-0197-3.
2
DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.是否有效?——一项针对中国美沙酮维持治疗点吸毒者的 HCV 和 HIV 相关教育效果的随机对照试验。
BMC Infect Dis. 2019 Sep 5;19(1):774. doi: 10.1186/s12879-019-4421-5.
3
Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China.中国上海接受美沙酮维持治疗的患者的丙型肝炎知识和酒精消费情况。
Am J Drug Alcohol Abuse. 2012 May;38(3):228-32. doi: 10.3109/00952990.2011.643974. Epub 2012 Jan 13.
4
Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China.在中国,丙型肝炎病毒感染与接受美沙酮维持治疗的海洛因使用者的抑郁症独立相关。
Asia Pac Psychiatry. 2013 Sep;5(3):191-6. doi: 10.1111/j.1758-5872.2012.00209.x. Epub 2012 Jul 27.
5
Who uses methadone services in China? Monitoring the world's largest methadone programme.谁在中国使用美沙酮服务?监测世界上最大的美沙酮计划。
Addiction. 2015 Jan;110 Suppl 1:29-39. doi: 10.1111/add.12781.
6
Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.中国武汉美沙酮维持治疗项目中的丙型肝炎血清学转换
Addiction. 2015 May;110(5):796-802. doi: 10.1111/add.12836. Epub 2015 Jan 22.
7
High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.台湾美沙酮维持治疗者中丙型肝炎病毒感染的高流行率与低知晓率。
Addict Behav. 2013 Apr;38(4):2089-93. doi: 10.1016/j.addbeh.2013.01.010. Epub 2013 Jan 17.
8
The role of the Chinese police in methadone maintenance therapy: a literature review.中国警察在美沙酮维持治疗中的作用:文献综述。
Int J Drug Policy. 2013 Nov;24(6):e25-34. doi: 10.1016/j.drugpo.2013.03.010. Epub 2013 Apr 25.
9
Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program.中国西南边境地区吸毒者中艾滋病毒、丙型肝炎病毒及合并感染的空间分布(2004 - 2014年):一项全国美沙酮维持治疗项目的队列研究
BMC Public Health. 2017 Sep 30;17(1):759. doi: 10.1186/s12889-017-4769-7.
10
Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study.中国广东省美沙酮维持治疗中控制 HIV 和 HCV 的策略:系统动力学建模研究。
Subst Abuse Treat Prev Policy. 2018 Jan 10;13(1):1. doi: 10.1186/s13011-017-0140-3.

引用本文的文献

1
Machine learning model for predicting hepatitis C seroconversion in methadone maintenance patients in China.中国美沙酮维持治疗患者丙型肝炎血清学转换预测的机器学习模型
BMJ Public Health. 2025 Aug 28;3(2):e002290. doi: 10.1136/bmjph-2024-002290. eCollection 2025.
2
Utilizing Theory of Planned Behaviour to increase intention to participate in hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT) in Malaysia: A cluster randomised control trial.利用计划行为理论提高马来西亚美沙酮维持治疗患者参与丙型肝炎治疗的意愿:一项整群随机对照试验。
PLoS One. 2025 May 22;20(5):e0324718. doi: 10.1371/journal.pone.0324718. eCollection 2025.
3
Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection.阿片类药物替代治疗的阿片类药物成瘾者的人格障碍与 HCV 感染的风险。
Front Public Health. 2022 Sep 9;10:1009413. doi: 10.3389/fpubh.2022.1009413. eCollection 2022.
4
Hepatitis C Virus Treatment Status and Barriers among Patients in Methadone Maintenance Treatment Clinics in Guangdong Province, China: A Cross-Sectional, Observational Study.中国广东省美沙酮维持治疗诊所中丙型肝炎病毒治疗状况和障碍:一项横断面、观察性研究。
Int J Environ Res Public Health. 2019 Nov 12;16(22):4436. doi: 10.3390/ijerph16224436.

本文引用的文献

1
HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.中国美沙酮维持治疗门诊入组者中 HIV 和 HCV 的流行率:系统评价和荟萃分析。
BMC Infect Dis. 2012 Jun 8;12:130. doi: 10.1186/1471-2334-12-130.
2
Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China.中国上海接受美沙酮维持治疗的患者的丙型肝炎知识和酒精消费情况。
Am J Drug Alcohol Abuse. 2012 May;38(3):228-32. doi: 10.3109/00952990.2011.643974. Epub 2012 Jan 13.
3
Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China.中国上海和昆明美沙酮维持治疗患者中的丙型肝炎。
J Public Health (Oxf). 2012 Mar;34(1):24-31. doi: 10.1093/pubmed/fdr098. Epub 2011 Dec 2.
4
Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.评估一项在中国注射吸毒者中控制艾滋病病毒的针头社会营销战略。
AIDS. 2007 Dec;21 Suppl 8:S115-22. doi: 10.1097/01.aids.0000304706.79541.ef.
5
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.整合多种针对注射吸毒者丙型肝炎预防和护理的项目及政策方法:一种综合方法。
Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20.
6
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.药物治疗项目患者的丙型肝炎病毒(HCV)教育需求及其对现有HCV教育服务的利用情况。
BMC Health Serv Res. 2007 Mar 8;7:39. doi: 10.1186/1472-6963-7-39.
7
Hepatitis C knowledge among staff in U.S. drug treatment programs.美国药物治疗项目工作人员对丙型肝炎的了解情况。
J Drug Educ. 2006;36(2):141-58. doi: 10.2190/3EMQ-N350-W4XN-WT1X.
8
Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications.中国注射吸毒与艾滋病毒/艾滋病:现状、预防及政策影响综述
Harm Reduct J. 2006 Feb 1;3:4. doi: 10.1186/1477-7517-3-4.
9
Knowledge of and interest in hepatitis C treatment at a methadone clinic.美沙酮诊所对丙型肝炎治疗的了解与兴趣。
J Subst Abuse Treat. 2005 Mar;28(2):181-7. doi: 10.1016/j.jsat.2004.12.004.
10
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.澳大利亚当前注射吸毒者对丙型肝炎病毒感染治疗的认识、态度及治疗障碍
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S313-20. doi: 10.1086/427446.

中国上海美沙酮维持治疗(MMT)诊所中丙型肝炎病毒感染者、相关服务及丙型肝炎病毒治疗障碍因素。

Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.

机构信息

Jiading Mental Health Center, Shanghai, China.

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Harm Reduct J. 2017 Nov 2;14(1):71. doi: 10.1186/s12954-017-0197-3.

DOI:10.1186/s12954-017-0197-3
PMID:29096647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5667515/
Abstract

BACKGROUND

The purpose of this study was to document the prevalence of hepatitis C among MMT patients, hepatitis C virus (HCV) knowledge of patients and MMT staff members, and the barriers preventing them from receiving or delivering HCV-related services in MMT clinics of China.

METHODS

Data were collected from 240 MMT patients and 58 staff members in Shanghai MMT clinics. Structured questionnaires (HCV Knowledge Scale and Alcohol Use Disorders Identification Test) and several self-developed questionnaires were used to assess (1) patient and staff HCV knowledge, (2) attitudes toward HCV-related services in MMT clinics, and (3) what type of HCV-related services the staff members have provided in their routine work. The HCV test results were based on the patients' medical records.

RESULTS

The HCV seropositive rate was high (70%), and both patients and staff had limited HCV knowledge. The mean score of patient HCV knowledge was 6.8 out of 20 (SD = 3.7), whereas the mean score of staff HCV knowledge was 10.9 out of 20 (SD = 3.1). For HCV-positive patients, only 13.7% had accessed HCV medical treatment. Barriers included the cost of medical treatment, lack of HCV knowledge, lack of professional training for patients to receive HCV-related services from individuals or MMT clinics, and lack of an adequate policy-making system.

CONCLUSIONS

HCV infection remains an important problem among MMT patients in China. Barriers to HCV-related services are attributable to individual, clinical, and policy-related factors. This study may provide evidence-based information for future work to optimize the resources of MMT clinics.

TRIAL REGISTRATION

ClinicalTrials.gov NCT01647191 . Registered 17 April 2012.

摘要

背景

本研究旨在记录中国美沙酮维持治疗(MMT)诊所内 MMT 患者、患者和 MMT 工作人员对丙型肝炎(HCV)的认知水平,以及阻碍他们在 MMT 诊所接受或提供 HCV 相关服务的因素。

方法

数据来源于上海 MMT 诊所的 240 名 MMT 患者和 58 名工作人员。采用结构式问卷(HCV 知识量表和酒精使用障碍识别测试)和几个自设问卷,评估(1)患者和工作人员对 HCV 的认知水平,(2)他们对 MMT 诊所内 HCV 相关服务的态度,以及(3)工作人员在日常工作中提供了哪些类型的 HCV 相关服务。HCV 检测结果基于患者的病历。

结果

HCV 血清阳性率较高(70%),患者和工作人员对 HCV 的了解都很有限。患者 HCV 知识的平均得分为 20 分中的 6.8 分(标准差=3.7),而工作人员 HCV 知识的平均得分为 20 分中的 10.9 分(标准差=3.1)。对于 HCV 阳性患者,仅有 13.7%接受了 HCV 治疗。阻碍因素包括治疗费用、缺乏 HCV 知识、缺乏对患者接受个体或 MMT 诊所 HCV 相关服务的专业培训,以及缺乏完善的政策制定体系。

结论

HCV 感染仍然是中国 MMT 患者面临的一个重要问题。阻碍 HCV 相关服务的因素可归因于个人、临床和政策相关因素。本研究可为未来优化 MMT 诊所资源的工作提供循证信息。

试验注册

ClinicalTrials.gov NCT01647191。于 2012 年 4 月 17 日注册。